跳到正文
原文
STAT Pharma 医药频道· John Wilkerson·· 2026-09-30AI 评分27

PhRMA 任命 Eric Cantor 为新任 CEO

STAT+: PhRMA taps Eric Cantor as new CEO

AI 导读

美国药品行业游说组织 PhRMA 周二宣布,前共和党众议院多数党领袖 Eric Cantor 将出任下一任 CEO。他上任之际,药价问题正面临两党日益升温的政治压力:特朗普政府试图把与二十多家企业达成的自愿降价协议写入法律,民主党则考虑将国际价格纳入 Medicare 谈判参考标准。

正文

Former GOP House majority leader is becoming top drug industry lobbyist at challenging time

Eric Cantor has been named as the next CEO of PhRMA.Heather Diehl/Getty Images

By John Wilkerson

Sept. 29, 2026

John Wilkerson, a Washington correspondent, is the author of D.C. Diagnosis, a twice-weekly newsletter about the politics and policy of health and medicine.

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.

WASHINGTON — Eric Cantor, a former GOP House majority leader, will be the next CEO of PhRMA, the lobbying group announced Tuesday. 

As head of the brand drug industry’s top lobbying group, Cantor will face mounting political pressure on drug prices and an increasingly populist mood from both political parties. 

The Trump administration is trying to codify into law voluntary agreements that it struck with more than two dozen companies to lower U.S. pharmaceutical prices to levels in peer countries. Democrats also are interested in that most-favored nation pricing approach and are considering adding international prices to the list of criteria Medicare uses to negotiate prices.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. Washington Correspondent

    John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.

来源:STAT Pharma 医药频道 · statnews.com